BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Adamsson J, Lundin SB, Hansson LE, Sjövall H, Svennerholm AM. Immune responses against Helicobacter pylori in gastric cancer patients and in risk groups for gastric cancer. Helicobacter 2013;18:73-82. [PMID: 23067268 DOI: 10.1111/j.1523-5378.2012.00991.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Arama SS, Tiliscan C, Negoita C, Croitoru A, Arama V, Mihai CM, Pop F, Garg A. Efficacy of 7-Day and 14-Day Triple Therapy Regimens for the Eradication of Helicobacter pylori: A Comparative Study in a Cohort of Romanian Patients. Gastroenterol Res Pract 2016;2016:5061640. [PMID: 26858750 DOI: 10.1155/2016/5061640] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
2 Adamsson J, Ottsjö LS, Lundin SB, Svennerholm A, Raghavan S. Gastric expression of IL-17A and IFNγ in Helicobacter pylori infected individuals is related to symptoms. Cytokine 2017;99:30-4. [DOI: 10.1016/j.cyto.2017.06.013] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
3 Garcia-Perez JC, Rodríguez-Perez R, Ballestero A, Zuloaga J, Fernandez-Puntero B, Arias-Díaz J, Caballero ML. Previous Exposure to the Fish Parasite Anisakis as a Potential Risk Factor for Gastric or Colon Adenocarcinoma. Medicine (Baltimore) 2015;94:e1699. [PMID: 26448021 DOI: 10.1097/MD.0000000000001699] [Cited by in Crossref: 25] [Cited by in F6Publishing: 12] [Article Influence: 4.2] [Reference Citation Analysis]
4 Gu JH, Wang XG, Wang LQ, Zhou LN, Tang M, Li P, Wu XY, Chen MB, Zhang Y. Serum level of interleukin-35 as a potential prognostic factor for gastric cancer. Asia Pac J Clin Oncol 2021;17:52-9. [PMID: 33044052 DOI: 10.1111/ajco.13403] [Reference Citation Analysis]
5 Yang L, Li C, Jia Y. MicroRNA-99b promotes Helicobacter pylori-induced autophagyand suppresses carcinogenesis by targeting mTOR. Oncol Lett 2018;16:5355-60. [PMID: 30250606 DOI: 10.3892/ol.2018.9269] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
6 Yolanda LV, Sergio PD, Hugo ES, Isabel AF, Rafael BZ, Aldo TD, Gonzalo CR. Gastric cancer progression associated with local humoral immune responses. BMC Cancer. 2015;15:924. [PMID: 26589831 DOI: 10.1186/s12885-015-1858-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
7 Kalali B, Formichella L, Gerhard M. Diagnosis of Helicobacter pylori: Changes towards the Future. Diseases 2015;3:122-35. [PMID: 28943614 DOI: 10.3390/diseases3030122] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
8 Besednova NN, Zaporozhets TS, Somova LM, Kuznetsova TA. Review: prospects for the use of extracts and polysaccharides from marine algae to prevent and treat the diseases caused by Helicobacter pylori. Helicobacter 2015;20:89-97. [PMID: 25660579 DOI: 10.1111/hel.12177] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 5.9] [Reference Citation Analysis]